An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs – used ...

A former scientist at Google's DeepMind who co-developed the AlphaFold2 protein prediction platform, Dr Simon Kohl, has launched his own venture applying artificial intelligence to drug discovery.

Global Life Science Leader Leverages Online Research Platform to Streamline Access to Its Cutting-Edge Drug Discovery and Development Solutions SAN DIEGO--(BUSINESS WIRE)--Scientist.com ...

A US clinical-stage biotechnology company has introduced the first bipedal humanoid robot in its AI-driven, fully automated ...

In the fast-paced world of drug discovery, staying updated with the latest advancements is crucial. This eBook offers a unique opportunity to explore a curated selection of posters that were ...

KQ Labs has supported 70 startups, which have raised over £219 million in investment. Applications for the next program open ...

The humanoid, called “Supervisor” will be used for data acquisition and data generation for training of the embodied AI systems to learn the skills of human laboratory scientists. The work ...

UCSF scientists have discovered how to target ... the GTPases have remained largely out of reach of modern drug discovery, with the exception of the notorious cancer-causing GTPase called K ...

However, I often hear from my life science clients about the need for ... based models like AlphaFold and DiffDock accelerate drug discovery, enabling de-novo compound generation.

(WWSB) - 35 years ago, a pair of scientists made a discovery that they believed would ... pathways that have begun breaking down. The new drug is for people in the early stages.

UCSF scientists have discovered how to target a large family ... this class of more than 100 enzymes has remained largely out of reach of modern drug discovery, with the exception of the notorious ...